Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -143,443 | -62,806 | -20,537 |
| Depreciation Amortization | -1,314 | -1,566 | -1,200 |
| Accounts receivable | -55 | -515 | 314 |
| Accounts payable and accrued liabilities | -1,281 | 2,017 | 1,278 |
| Other Working Capital | 589 | 1,873 | -4,305 |
| Other Operating Activity | 12,229 | 1,825 | -13,476 |
| Operating Cash Flow | $-133,275 | $-59,172 | $-37,926 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -93,315 | -58,974 | -82,698 |
| PPE Investments | -165 | -511 | -144 |
| Investing Cash Flow | $-93,480 | $-59,485 | $-82,842 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 2,475 | 272,882 | 118 |
| Other Financing Activity | -34 | 146,028 | 129,432 |
| Financing Cash Flow | $2,441 | $418,910 | $129,550 |
| Beginning Cash Position | 326,086 | 25,833 | 17,051 |
| End Cash Position | 101,772 | 326,086 | 25,833 |
| Net Cash Flow | $-224,314 | $300,253 | $8,782 |
| Free Cash Flow | |||
| Operating Cash Flow | -133,275 | -59,172 | -37,926 |
| Capital Expenditure | -165 | -511 | -144 |
| Free Cash Flow | -133,440 | -59,683 | -38,070 |